Symbol | Exchange | Currency |
|---|
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life...
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life...
Findings in Nature Communications Provide Insights That May Help Guide Patient CareResearch Study Conducted in Collaboration with Fluidigm's Therapeutic Insights ServicesSOUTH...
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Neutral | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 148.67 | 149.69 | 148.49 | -0.65 | -0.44% | 4.77M | NASDAQ | |||
| 317.00 | 318.90 | 312.30 | +1.19 | +0.38% | 2.95M | NASDAQ | |||
| 2,803.00 | 2,820.70 | 2,791.80 | +16.9 | +0.61% | 271.41K | NASDAQ | |||
| 55.98 | 56.08 | 55.59 | +1.51 | +2.77% | 3.84M | NYSE | |||
| 48.59 | 48.81 | 48.49 | +0.31 | +0.64% | 3.34M | NASDAQ | |||
| 622.77 | 625.00 | 616.95 | +14.43 | +2.37% | 174.74K | NYSE | |||
| 54.73 | 55.74 | 54.66 | -2.64 | -4.60% | 6.93M | NYSE | |||
| 2.35 | 2.36 | 2.34 | -0.010 | -0.42% | 12.99K | NYSE | |||
| 247.32 | 247.55 | 242.88 | +0.15 | +0.06% | 2.58M | NASDAQ | |||
| 171.32 | 171.93 | 167.37 | +1.33 | +0.78% | 1.41M | NYSE | |||
| 2.50 | 2.96 | 2.38 | +0.980 | +64.47% | 44.51M | NASDAQ | |||
| 19.50 | 19.66 | 19.50 | -0.19 | -0.96% | 14.59K | NASDAQ | |||
| 311.67 | 312.00 | 306.50 | -7.82 | -2.45% | 693.43K | NASDAQ | |||
| 668.12 | 670.18 | 667.42 | -0.40 | -0.06% | 155.55K | NASDAQ | |||
| 36.71 | 37.18 | 36.65 | +0.27 | +0.74% | 447.21K | NASDAQ |
Fluidigm Corporation creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents, and software that are used by researchers and clinical labs. The Company operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. It markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.